7 stories about Quris
Michel Yossi Quris

Quris-AI appoints Michel Vounatsos and Yossi Ben Amram in key roles

Vounatsos was appointed Board member and Ben Amram was appointed President, respectively.
ד״ר צחון בנטואיץ׳ מייסד משותף של קיוריס Quris AI

Pharma giant Merck expands collaboration with Quris-AI

28.09.23|Meir Orbach
This follows the successful initial collaboration, a preclinical study to assess Quris-AI’s ability to predict drug toxicity in comparison to traditional in vitro and in vivo approaches
יוסי הרן צחון בנטואיץ Quris

SoftBank leads $9 million investment in AI pharma startup Quris

20.12.22|Meir Orbach
The Israeli startup expanded its Seed funding to $37 million and plans to use the additional investment to advance its Bio-AI clinical-prediction platform that simulates clinical trials
Isaac Bentwich  BiblioTech

CTech’s Book Review: Breaking down the barriers to set you free

13.07.22|Isaac Bentwich
Isaac Bentwich, Founder and CEO of Quris Technologies, shares insights after reading “Untethered Soul” by Michael A. Singer
מימין אהרון צ'חנובר יו"ר הוועדה המדעית בקיוריס והמנכ"ל צחון בנטואיץ'

Pharma giant Merck inks deal with Israel’s Quris for clinical safety prediction

09.02.22|Meir Orbach
The Israeli company which develops predictive technology based on artificial intelligence has signed an agreement worth tens of millions of dollars to test drugs by the pharma giant
Quris Isaac Bentwich

Quris closes record $28 million Seed funding for AI drug development platform

11.01.22|Meir Orbach
The Israeli startup uses AI-powered miniaturized “patients-on-a-chip” to avoid the risks and costs of failed clinical trials and eliminate the reliance on ineffective animal testing
Quris Isaac Bentwich

Quris raises $9 million in Seed for its clinician prediction AI platform

21.10.21|James Spiro
The announcement coincides with the launch of its platform via a partnership with the NYSCF Research Institute.